Results 171 to 180 of about 3,185 (196)

DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson’s Individuals with GBA1 Mutations [PDF]

open access: yesInternational Journal of Molecular Sciences, 2023
Parkinson’s disease (PD) is a common movement disorder, estimated to affect 4% of individuals by the age of 80. Mutations in the glucocerebrosidase 1 (GBA1) gene represent the most common genetic risk factor for PD, with at least 7–10% of non-Ashkenazi ...
Adam R Smith   +2 more
exaly   +1 more source

EXPRESSION OF AUTOPHAGY-RELATED GENES IN GBA1 MUTATIONS CARRIERS WITH AND WITHOUT PARKINSON’S DISEASE

X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023: Cб. тез., 2023
The molecular mechanisms of the neurodegenerative disease, Parkinson’s disease (PD), associated with mutations in the GBA1 gene (GBA-PD) are unknown. Recent data point to the role of autophagy, in particular of the PI3K/AKT/mTOR pathway, in PD pathogenesis.
A.I. Bezrukova   +4 more
openaire   +1 more source

Autophagy Process in Parkinson’s Disease Depends on Mutations in the GBA1 and LRRK2 Genes

Biochemical Genetics
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and abnormal aggregation of the alpha-synuclein protein. Disruption of the autophagy-lysosomal pathway is closely associated with PD pathogenesis.
A I, Bezrukova   +6 more
openaire   +2 more sources

Use of a multiplex ligation-dependent probe amplification method for the detection of deletions/duplications in the GBA1 gene in Gaucher disease patients

Blood Cells, Molecules, and Diseases, 2018
Gaucher disease (GD) is caused by the deficient activity of β-glucocerebrosidase due to pathogenic mutations in the GBA1. This gene has a pseudogene (GBAP) with 96% of sequence homology. Recombination (Rec) events in the GBA1 seem to be facilitated by an increased degree of homology and proximity to the GBAP.
Suelen P, Basgalupp   +6 more
openaire   +2 more sources

MTOR-A POTENTIAL THERAPEUTIC TARGET FOR PARKINSON’S DISEASE WITH MUTATIONS IN THE GBA1 GENE

XI Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов, молекулярных биологов и специалистов фундаментальной медицины — 2024 : сб. тез.
The molecular mechanisms of the neurodegenerative disorder Parkinson’s disease (PD) associated with mutations in the GBA1 gene which encodes the lysosomal enzyme glucocerebrosidase (GCase) gene, (GBA1-PD) are unknown. Transcriptome analysis of cellular and animal models with induced parkinsonism and GCase dysfunction, followed by subsequent validation,
A.I. Bezrukova   +8 more
openaire   +1 more source

A Global Perspective of GBA1-Related Parkinson’s Disease: A Narrative Review

open access: yesGenes
Parkinson’s disease (PD) is considered to be the second most prominent neurodegenerative disease and has a global prevalence. Glucocerebrosidase (GBA1) gene mutations represent a significant hereditary risk factor for the development of PD and have a ...
Christos Koros   +2 more
exaly   +1 more source

Safety and activity of gene therapy with AAV8 GBA1 (LY-M001)on type I adults gaucher disease

Blood
Abstract Background: Gaucher disease (GD) is a rare autosomal recessive disorder caused by GBA1 mutations, leading to deficient glucocerebrosidase (GCase) activity and accumulation of glucosylceramide (GlcCer) and glucosylsphingosine (Lyso-GL1), resulting in multisystemic involvement.
Yishan Ye   +6 more
openaire   +1 more source

Mutations in the GBA1 gene in Spanish population with Parkinson disease and plasma miRNA

Molecular Genetics and Metabolism, 2016
Pilar Alfonso   +5 more
openaire   +1 more source

GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance

International Journal of Molecular Sciences, 2023
Zuzanna Granek   +2 more
exaly  

Home - About - Disclaimer - Privacy